Zydus Lifesciences
BSE: 532321 | NSE: ZYDUSLIFE | ISIN: INE010B01027 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
14.77Net Income/employee - trailing 12 month
12,82,985.00Revenue/employee - most recent fiscal year
73,71,293.00Return on investment - most recent fiscal year
11.14Return on average assets - most recent fiscal year
7.48Receivables turnover - most recent fiscal year
4.44Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.89Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
81,13,133.00Return on average assets - 5 year average
7.92Net Income/employee - most recent fiscal year
8,56,079.90Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.64Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
11.39Return on investment - 5 year average
12.61